Study of a Propranolol (HEMANGIOL®) and Oral Metronomic Vinorelbine (NAVELBINE®) Combination for Children and Teenagers With Refractory/Relapsing Solid Tumors

NCT02897986 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Pediatric Cancer

Interventions

DRUG: administration of a propranolol (HEMANGIOL®) and oral metronomic vinorelbine (NAVELBINE®) combination

Sponsor

Assistance Publique Hopitaux De Marseille